Ghrelin in small-for-gestational age (SGA) newborn babies: a cross-sectional study

Francisco Méndez-Ramírez1, Gloria Barbosa-Sabanero, Gustavo Romero-Gutiérrez

  • 1Instituto de Investigaciones Médicas, Universidad de Guanajuato, Guanajuato, México.

Clinical Endocrinology
|April 19, 2008
PubMed

Insights

Small-for-gestational age (SGA) newborns show altered hormone levels, including lower IGF-1 and higher ghrelin. These hormonal changes suggest adaptive responses to diminished birth weight, potentially influencing long-term metabolic health.

Area of Science:

  • Endocrinology
  • Neonatal Research
  • Metabolic Health

Background:

  • Small-for-gestational age (SGA) newborns face potential long-term metabolic challenges.
  • Hormones like Insulin-like Growth Factors (IGFs), IGF-Binding Proteins (IGFBPs), and ghrelin are implicated in fetal growth regulation.

Purpose of the Study:

  • To compare desacyl-ghrelin, IGF-1, IGFBP-1, and IGFBP-3 levels in SGA versus adequate-for-gestational age (AGA) children.
  • Investigate hormonal profiles associated with SGA status.

Main Methods:

  • Cross-sectional, comparative study design.
  • Inclusion of 40 SGA and 40 AGA children.
  • Blood samples collected one week post-birth, with hormonal assays performed using ELISA.

Main Results:

  • SGA infants exhibited lower IGF-1, IGFBP-3, and leptin levels.
  • SGA infants demonstrated higher ghrelin and IGFBP-1 levels.
  • Birth weight correlated negatively with ghrelin and IGFBP-1, and positively with IGFBP-3; maternal ghrelin levels were inversely associated with IGFBP-3 and triglycerides.

Conclusions:

  • Diminished birth weight in newborns triggers adaptive hormonal signals, involving IGF-1/IGFBP-3, ghrelin, and IGFBP-1.
  • Ghrelin's role in adapting to under-nutrition, potentially promoting lipid accumulation, is supported by these findings.
Abstract

Related Concept Videos